MedPath

深圳善康医药科技股份有限公司

Ownership
-
Established
2017-10-24
Employees
-
Market Cap
-
Website
www.sciencare.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Naltrexone Hydrochloride Implants

Product Name
盐酸纳曲酮植入剂
Approval Number
国药准字H20240031
Approval Date
Jun 25, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.